Cellphire Therapeutics
PrivateLast Round
Series A
Apr 2, 2021
Total Funding Raised
$104.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellphire Therapeutics operates in Healthcare & Life Sciences and is based in Rockville, Maryland. Its latest recorded funding round was a Series A round in April 2021.
Cellphire Therapeutics is a clinical-stage biotechnology company that develops next-generation platelet-derived therapeutics to treat hemorrhaging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellphire Therapeutics Comparables
Compare Cellphire Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Haima Therapeutics | 81% | |
| Cayuga Biotech | 73% | |
| Velico Medical | 72% |
For institutional investors. Book with your work email.
Cellphire Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 2, 2021 | ||||
| Grant | Jan 15, 2020 | ||||
| Early Funding | Jun 5, 2017 | ||||
| VC Round | Jun 10, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellphire Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TEDCO | VC Round |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| U.S. Army Medical Research Acquisition Activity | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 47% MoM.
- Aug 17, 2026
Open roles doubled to 10, representing 21% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 22, 2026
Humberto Moran joins Cellphire, Inc. from Sensei Bio after serving as Vice President, Tech Ops, Quality & Maryland Site Head.
- hiresSep 22, 2026
Cellphire, Inc. hires Humberto Moran as Vice President of Manufacturing Technical Operations, bringing more than 20 years of technical operations, quality, and supply chain leadership across clinical-stage biotech and global biopharmaceutical companies.
For institutional investors. Book with your work email.
Cellphire Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellphire Therapeutics's valuation, stock price, and market status.
Is Cellphire Therapeutics a public or private company?
Cellphire Therapeutics is a private company.
What is the current stock price of Cellphire Therapeutics?
Cellphire Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cellphire Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellphire Therapeutics worth (valuation)?
Valuation information for Cellphire Therapeutics is not publicly available.
Can I buy Cellphire Therapeutics stock?
Cellphire Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellphire Therapeutics's last funding round?
Cellphire Therapeutics's most recent funding round was Series A on April 2, 2021.
Who are the main investors in Cellphire Therapeutics?
Key investors in Cellphire Therapeutics include TEDCO, Public Health Emergency Medical Countermeasures Enterprise, U.S. Army Medical Research Acquisition Activity.
Will Cellphire Therapeutics IPO soon?
No public IPO plans have been announced for Cellphire Therapeutics.
How can I track Cellphire Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cellphire Therapeutics's shares on secondary markets.